Jerome Benedict Durso - 31 Dec 2022 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.

Role
President & CEO, Director
Signature
/s/ Rocco Venezia
Issuer symbol
N/A
Transactions as of
31 Dec 2022
Net transactions value
-$87,617
Form type
4
Filing time
03 Jan 2023, 15:01:47 UTC
Previous filing
31 Jan 2022
Next filing
31 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability $87,617 -7,083 -6.4% $12.37 104,240 31 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person.